Leif Göran Kvist
Geen lopende functies
Profiel
Leif Göran Kvist was the founder of Dilafor AB, which was founded in 2003, where he held the title of Chairman.
Mr. Kvist is also the founder of Modus Therapeutics AB, QP Support AB.
He previously held the position of Chairman & Chief Executive Officer at TQ Kvalitetskonsult AB and Director at AcuCort AB.
Mr. Kvist obtained an undergraduate degree from the University of Uppsala.
Eerdere bekende functies van Leif Göran Kvist
| Bedrijven | Functie | Einde |
|---|---|---|
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Oprichter | - |
| QP Support AB | Oprichter | - |
| ACUCORT AB | Directeur/Bestuurslid | - |
TQ Kvalitetskonsult AB
 TQ Kvalitetskonsult AB Miscellaneous Commercial ServicesCommercial Services TQ Kvalitetskonsult AB provides science and technology research and development services. The private company is based in Morarp, Sweden. | Algemeen Directeur | - |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Oprichter | - |
Opleiding van Leif Göran Kvist
| University of Uppsala | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ACUCORT AB | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Health Technology |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Health Technology |
TQ Kvalitetskonsult AB
TQ Kvalitetskonsult AB Miscellaneous Commercial ServicesCommercial Services TQ Kvalitetskonsult AB provides science and technology research and development services. The private company is based in Morarp, Sweden. | Commercial Services |
| QP Support AB |
